BDC2.5 Mimotope 1040-63 - 1 mg
- Cat.Number : AS-63774
- Manufacturer Ref. :
-
Availability :
In stock
Alternative choices
The TCR transgenic model (BDC2.5) mimitope was used in type 1 diabetes (T1D) study. T1D is an autoimmune disease in which T cells mediate damage to pancreatic islet b cells. T1D is caused by autoreactive T cell destruction of insulin-producing cells. BDC2.5 mimotope was utilized to support the study on antigen presentation of antigenic peptides to islet autoantigen-specific T cells.
Specifications
Chemistry | |
Sequence one letter code |
|
---|---|
Sequence three letter code |
|
Molecular Formula |
|
Molecular Mass/ Weight |
|
Modification | |
Conjugation |
|
Quantity & Purity | |
Purity |
|
Storage & stability | |
Form |
|
Storage Conditions |
|
Activity | |
Biomarker Target | |
Research Area | |
Sub-category Research Area | |
Usage |
|
Source | |
Source / Species |
|
You may also be interested in the following product(s)


References
Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice
J Clin Invest. . 2007 Dec 03 ; 117 3857 | DOI : 10.1172/JCI32405
- C. Hu
- et al
Paradoxical Dampening of Anti-Islet Self-Reactivity but Promotion of Diabetes by OX40 Ligand
J Immunol . 2003 Dec 15 ; 171 3857 | DOI : https://doi.org/10.4049/jimmunol.171.12.6954
- N. Martin-Orozco
- et al